Trial reportFrontiers in neuroscience2026
NeuroVision training may improve subjective visual quality in patients with residual refractive error after SMILE: a prospective clinical trial.
Trial report in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To study the improvement of subjective visual quality in patients with a small amount of residual refraction and poor visual quality after small incision ienticule extraction (SMILE) surgery through visual cortex training. Methods: Eleven subjects (22 eyes) aged 18-40 years who had undergone SMILE >6 months previously were prospectively enrolled. Subjects were trained 30 times, with the pre-training period as the baseline. Untrained patients from the same period were enrolled as controls. Results: The contrast sensitivity, best corrected visual acuity (BCVA), glare symptoms, and stereoscopic vision of the subjects was improved after training compared with before training. Compared with the eye with poor vision before training, the contrast sensitivity of the eye with good vision before training improved after training. There was no significant change in the no corrected visual acuity (NCVA) and refraction before and after training. After 12 months, contrast sensitivity was better in the visual cortex training group. Conclusion: For patients with a small amount of residual refractive error and reduced subjective visual quality after SMILE, RevitalVision training improved subjective visual function, particularly contrast sensitivity and related visual performance, without measurable changes in objective optical quality parameters. Clinical trial registration: Identifier [ChiCTR1800014796].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.